Hit Triage and Validation in Phenotypic Screening: Considerations and Strategies

Area of Science:

• Drug discovery and development
• Pharmacology
• Biotechnology

Background:

• Phenotypic screening has a history of identifying novel biological pathways and first-in-class drugs.
• Significant differences exist between target-based and phenotypic screening approaches, posing challenges for hit validation.
• The mechanisms of action for phenotypic screening hits are often unknown, complicating the path to clinical candidates.

Purpose of the Study:

• To re-evaluate the hit triage and validation process for phenotypic screening.
• To identify critical knowledge types that facilitate the progression of phenotypic screening hits.
• To assess the utility of structure-based approaches in phenotypic hit triage.

Main Methods:

• Analysis of the hit triage and validation process in drug discovery.
• Review of knowledge integration strategies for phenotypic screening hits.
• Comparative assessment of different hit triage methodologies.

Main Results:

• Phenotypic screening hits often involve complex and poorly understood biological mechanisms.
• Successful hit triage and validation depend on integrating three key knowledge areas: known mechanisms, disease biology, and safety profiles.
• Structure-based hit triage may hinder rather than help the validation of phenotypic screening hits.

Conclusions:

• A knowledge-driven approach, incorporating known mechanisms, disease biology, and safety, is crucial for effective phenotypic screening hit validation.
• Rethinking hit triage strategies is essential to overcome the challenges associated with phenotypic screening.
• Future drug discovery efforts should prioritize integrated biological knowledge over structure-based methods for phenotypic screening.